Clinical trials recruiting for SMARCA4-Deficient Tumor
Fewer than 3 recruiting trials found.
1
Recruiting trials
11
US states with sites
6
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin | 1 |
| Cisplatin | 1 |
| LY4050784 | 1 |
| Nab-paclitaxel | 1 |
| Paclitaxel | 1 |
| Pembrolizumab | 1 |
| Pemetrexed | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Colorado | 1 |
| Florida | 1 |
| Illinois | 1 |
| Massachusetts | 1 |
| New York | 1 |
| Ohio | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Virginia | 1 |
| Wisconsin | 1 |
Top cities
Aurora, Colorado 1Boston, Massachusetts 1Columbus, Ohio 1Denver, Colorado 1Fairfax, Virginia 1Houston, Texas 1Lake Mary, Florida 1Miami, Florida 1Milwaukee, Wisconsin 1Nashville, Tennessee 1
Self-screener
Recruiting trials
Related conditions
Trials recruiting for SMARCA4-Deficient Tumor often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for SMARCA4-Deficient Tumor trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.